401 related articles for article (PubMed ID: 18791173)
1. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.
Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):793-800. PubMed ID: 18791173
[TBL] [Abstract][Full Text] [Related]
2. MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.
Liu B; Frost JL; Sun J; Fu H; Grimes S; Blackburn P; Lemere CA
J Neurosci; 2013 Apr; 33(16):7027-37. PubMed ID: 23595760
[TBL] [Abstract][Full Text] [Related]
3. Nonamyloidogenic processing of amyloid beta precursor protein is associated with retinal function improvement in aging male APP
Joly S; Lamoureux S; Pernet V
Neurobiol Aging; 2017 May; 53():181-191. PubMed ID: 28262325
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice.
Sivasaravanaparan M; Olesen LØ; Severino M; von Linstow CU; Lambertsen KL; Gramsbergen JB; Hasselstrøm J; Metaxas A; Wiborg O; Finsen B
J Alzheimers Dis; 2022; 87(2):685-699. PubMed ID: 35342093
[TBL] [Abstract][Full Text] [Related]
5. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.
Perez SE; Dar S; Ikonomovic MD; DeKosky ST; Mufson EJ
Neurobiol Dis; 2007 Oct; 28(1):3-15. PubMed ID: 17662610
[TBL] [Abstract][Full Text] [Related]
7. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Khan N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1740-1750. PubMed ID: 32542833
[TBL] [Abstract][Full Text] [Related]
9. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
[TBL] [Abstract][Full Text] [Related]
10. Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse.
Gupta VK; Chitranshi N; Gupta VB; Golzan M; Dheer Y; Wall RV; Georgevsky D; King AE; Vickers JC; Chung R; Graham S
Neurosci Lett; 2016 Jun; 623():52-6. PubMed ID: 27133194
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.
Liu B; Rasool S; Yang Z; Glabe CG; Schreiber SS; Ge J; Tan Z
Am J Pathol; 2009 Nov; 175(5):2099-110. PubMed ID: 19834067
[TBL] [Abstract][Full Text] [Related]
12. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
Choi SH; Leight SN; Lee VM; Li T; Wong PC; Johnson JA; Saraiva MJ; Sisodia SS
J Neurosci; 2007 Jun; 27(26):7006-10. PubMed ID: 17596449
[TBL] [Abstract][Full Text] [Related]
13. Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice.
Perez SE; Lazarov O; Koprich JB; Chen EY; Rodriguez-Menendez V; Lipton JW; Sisodia SS; Mufson EJ
J Neurosci; 2005 Nov; 25(44):10220-9. PubMed ID: 16267229
[TBL] [Abstract][Full Text] [Related]
14. Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.
Kelley CM; Perez SE; Overk CR; Wynick D; Mufson EJ
J Alzheimers Dis; 2011; 25(3):491-504. PubMed ID: 21471639
[TBL] [Abstract][Full Text] [Related]
15. A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
Parthsarathy V; McClean PL; Hölscher C; Taylor M; Tinker C; Jones G; Kolosov O; Salvati E; Gregori M; Masserini M; Allsop D
PLoS One; 2013; 8(1):e54769. PubMed ID: 23382963
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
[TBL] [Abstract][Full Text] [Related]
17. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
[TBL] [Abstract][Full Text] [Related]
18. The Lack of Amyloidogenic Activity Is Persistent in Old WT and APP
Joly S; Rodriguez L; Pernet V
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768774
[TBL] [Abstract][Full Text] [Related]
19. Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease.
Oliveira-Souza FG; DeRamus ML; van Groen T; Lambert AE; Bolding MS; Strang CE
Neuroscience; 2017 Jun; 354():43-53. PubMed ID: 28450267
[TBL] [Abstract][Full Text] [Related]
20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
